Peptide Retatrutide 5mg/vial 10mg/vial
Retatrutide (LY3437943) is an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors. Its dose–response relationships with respect to side effects, safety, and efficacy for the treatment of obesity are not known. Methods We conducted a phase 2, double-blind, randomized, placebo-controlled trial involving adults who had a body-mass index (BMI, the weight in kilograms divided by the …
Tirzepatide 5mg/vial Peptide Mounjaro 10mg/vial
Tirzepatide is indicated to improve blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise. Tirzepatide is also indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management. Tirzepatide has demonstrated significant benefits in obese patients with a common type of heart failure, preserved ejection fraction (HFpEF) in …
Are you looking into tirzepatide for a specific condition and how it works?
Tirzepatide is a medication primarily used for the treatment of type 2 diabetes and obesity. It’s a dual GIP (Gastric Inhibitory Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptor agonist. By targeting both of these hormones, tirzepatide helps regulate blood sugar levels, promote insulin secretion, and reduce appetite, leading to weight loss. It’s sold under the brand name Mounjaro. Tirzepatide has gained …
